Oncotelic, TechForce Partner on AI Robotics Platform

Oncotelic Therapeutics has announced a strategic partnership with TechForce Robotics to commercialize an AI-enhanced, GMP-compliant robotics platform. The system combines Oncotelic's proprietary PDAOAI technology with TechForce's robotics hardware to automate pharmaceutical manufacturing workflows. The integrated platform is designed for GMP-regulated environments, enabling automated material handling, real-time monitoring, and compliance workflows. Key features include reduced human intervention, minimized contamination risk, audit readiness, and scalable manufacturing capability through TechForce's hardware network.